ATC | B/G | Ingredients | code | Registration Nb | Name | Dosage | Presentation | Form | Route | Agent | Laboratory | Country | Price | Pharmacist Margin | Stratum | Responsible Party Name | Responsible Party Country | Exch_date | %SUBSIDY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
A16AB07 | BioTech | Alglucosidase alfa, recombinant human acid - 50mg | 8281 | 9815/1 | MYOZYME | 50mg | 1 | Injectable powder for concentrate for solution | Infusion | Mersaco | Genzyme Ireland Ltd | Ireland | 865,861 L.L | 10.71 | E1 | Genzyme Europe BV | The Netherlands | 2/5/2024 |
ATC | B/G | Ingredients | code | Registration Nb | Name | Dosage | Presentation | Form | Route | Agent | Laboratory | Country | Price | Pharmacist Margin | Stratum | Responsible Party Name | Responsible Party Country | Exch_date | %SUBSIDY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
A16AB07 | BioTech | Alglucosidase alfa, recombinant human acid - 50mg | 8281/945 | 9815/1 | MYOZYME | 50mg | 1 | Injectable powder for concentrate for solution | Infusion | Mersaco | Genzyme Ireland Ltd | Ireland | 52,788,606 L.L | 10.71 | E1 | Genzyme Europe BV | The Netherlands | 2/5/2024 | 0 |